PPQJX
Price
$7.81
Change
-$0.04 (-0.51%)
Updated
Sep 20 closing price
RRMGX
Price
$97.44
Change
-$0.69 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

PPQJX vs RRMGX

Header iconPPQJX vs RRMGX Comparison
Open Charts PPQJX vs RRMGXBanner chart's image
Principal MidCap Growth III J
Price$7.81
Change-$0.04 (-0.51%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth R
Price$97.44
Change-$0.69 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PPQJX vs RRMGX Comparison Chart
Loading...
VS
PPQJX vs. RRMGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PPQJX is a StrongBuy and RRMGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 31.4B vs. PPQJX (447M). PPQJX (0.00) and RRMGX (0.00) have matching dividends . PPQJX was incepted earlier than RRMGX: PPQJX (24 years) vs RRMGX (22 years). PPQJX is a more actively managed with annual turnover of: 49.40 vs. RRMGX (21.70). PPQJX has a lower initial minimum investment than RRMGX: PPQJX (1000) vs RRMGX (2500). RRMGX annual gain was more profitable for investors over the last year : 13.62 vs. PPQJX (6.11). RRMGX return over 5 years is better than : 9.23 vs. PPQJX (-18.65).
PPQJXRRMGXPPQJX / RRMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years22 years-
Gain YTD3.5818.60542%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets447M31.4B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year6.1113.6245%
Returns for 3 years-40.61-16.28249%
Returns for 5 years-18.659.23-202%
Returns for 10 years-28.9433.74-86%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OII26.020.16
+0.62%
Oceaneering International
COTY9.19-0.20
-2.13%
COTY
CLCO11.05-0.30
-2.64%
Cool Company Ltd
QLGN0.17-0.01
-3.55%
Qualigen Therapeutics
PRPH2.34-0.17
-6.77%
ProPhase Labs